Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor

Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor

US Patent 7019112 · Granted Mar 28, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rapid identification and sequence analysis of intact proteins in complex mixture2025
Rapid identification and sequence analysis of intact proteins in complex mixture2025
Target peptides for immunotherapy and diagnostics2024
Target peptides for immunotherapy and diagnostics2024
Target peptides for immunotherapy and diagnostics2024
Isolated T cell receptors and methods of use therefor2024
Compositions and methods for treating melanoma2023
Rapid identification and sequence analysis of intact proteins in complex mixture2022
Rapid identification and sequence analysis of intact proteins in complex mixture2022
Identification of MHC class I phospho-peptide antigens from breast cancer utiliz2022
Identification of MHC class I phospho-peptide antigens from breast cancer utiliz2022
Target peptides for colorectal cancer therapy and diagnostics2020